|
|
Volumn 21, Issue 5-6, 1999, Pages 1009-1060
|
|
1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension
|
|
Author keywords
Clinical evaluation; Definition and classification of hypertension; Management of hypertension; Risk stratification for hypertension; Special populations with hypertension
|
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ANGIOTENSIN RECEPTOR ANTAGONIST;
ANTIHYPERTENSIVE AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM ANTAGONIST;
CAPTOPRIL;
CLONIDINE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
FELODIPINE;
HYDRALAZINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
METHYLDOPA;
MOXONIDINE;
NITRENDIPINE;
RESERPINE;
RILMENIDINE;
VASODILATOR AGENT;
AGING;
ANKLE EDEMA;
CEREBROVASCULAR ACCIDENT;
COMORBIDITY;
CONFERENCE PAPER;
CONSTIPATION;
COUGHING;
DIABETES MELLITUS;
DIET RESTRICTION;
DRUG MIXTURE;
FLUSHING;
HEADACHE;
HUMAN;
HYPERTENSION;
KIDNEY DISEASE;
SMOKING CESSATION;
STROKE;
TACHYCARDIA;
WORLD HEALTH ORGANIZATION;
|
|
EID: 0032811393
PISSN: 10641963
EISSN: None
Source Type: Journal
DOI: 10.3109/10641969909061028 Document Type: Conference Paper |
|
Times cited : (503)
|
|
References (199)
|
